1 |
Diehl, J.A., F. Zindy and C.J. Sherr. 1997. Inhibition of cyclin D1 phosphorylation on threonine-286 prevents its rapid degradation via the ubiquitin-proteasome pathway. Genes Dev. 11:957-972.
DOI
|
2 |
Diehl, J.A., M. Cheng, M.F. Roussel and C.J. Sherr. 1998. Glycogen synthase kinase-3beta regulates cyclin D1 proteolysis and subcellular localization. Genes Dev. 12:3499-3511.
DOI
|
3 |
Benzeno, S., F. Lu, M. Guo, O. Barbash, F. Zhang, J.G. Herman, P.S. Klein, A. Rustgi and J.A. Diehl. 2006. Identification of mutations that disrupt phosphorylation-dependent nuclear export of cyclin D1. Oncogene 25:6291-6303.
DOI
|
4 |
Bahnassy, A.A., A.R.N. Zekri, S. El-Houssini, A.M.R. El-Shehaby, M.R. Mahmoud, S. Abdallah and M. El-Serafi. 2004. Cyclin A and cyclin D1 as significant prognostic markers in colorectal cancer patients. BMC Gastroenterol. 4:22.
DOI
|
5 |
Alao, J.P., A.V. Stavropoulou, E.W. Lam, R.C. Coombes and D.M. Vigushin. 2006. Histone deacetylase inhibitor, trichostatin A induces ubiquitin-dependent cyclin D1 degradation in MCF-7 breast cancer cells. Mol. Cancer 5:8.
|
6 |
Alao, J.P., E.W. Lam, S. Ali, L. Buluwela, W. Bordogna, P. Lockey, R. Varshochi, A.V. Stavropoulou, R.C. Coombes and D.M. Vigushin. 2004. Histone deacetylase inhibitor trichostatin A represses estrogen receptor alpha-dependent transcription and promotes proteasomal degradation of cyclin D1 in human breast carcinoma cell lines. Clin. Cancer Res. 10:8094-8104.
DOI
|
7 |
Alao, J.P. 2007. The regulation of cyclin D1 degradation: roles in cancer development and the potential for therapeutic invention. Mol. Cancer 6:24.
|
8 |
Li, H.M., J.K. Kim, J.M. Jang, C.B. Cui and S.S. Lim. 2013. Analysis of the inhibitory activity of Abeliophyllum distichum leaf constituents against aldose reductase by using high-speed counter current chromatography. Arch. Pharm. Res. 36:1104-1112.
DOI
|
9 |
Lee, K.W., H.J. Kim, Y.S. Lee, H.J. Park, J.W. Choi, J. Ha and K.T. Lee. 2007. Acteoside inhibits human promyelocytic HL-60 leukemia cell proliferation via inducing cell cycle arrest at G0/G1 phase and differentiation into monocyte. Carcinogenesis 28:1928-1936.
DOI
|
10 |
Langenfeld, J., H. Kiyokawa, D. Sekula, J. Boyle and E. Dmitrovsky. 1997. Posttranslational regulation of cyclin D1 by retinoic acid: a chemoprevention mechanism. Proc. Natl. Acad. Sci. USA. 94:12070-12074.
DOI
|
11 |
Kwak, Y.T., R. Li, C.R. Becerra, D. Tripathy, E.P. Frenkel and U.N. Verma. 2005. IkappaB kinase alpha regulates subcellular distribution and turnover of cyclin D1 by phosphorylation. J. Biol. Chem. 280:33945-33952.
DOI
|
12 |
Kim, H.J., N. Hawke and A.S. Baldwin. 2006. NF-kappaB and IKK as therapeutic targets in cancer. Cell Death Differ. 13:738-747.
DOI
|
13 |
Kato, J., H. Matsushime, S.W. Hiebert, M.E. Ewen and C.J. Sherr. 1993. Direct binding of cyclin D to the retinoblastoma gene product (pRb) and pRb phosphorylation by the cyclin D-dependent kinase CDK4. Genes Dev. 7:331-342.
DOI
|
14 |
Jeong, J.B., X. Yang, C. Ruth, J. Choi, S.J. Baek and S.H. Lee. 2013. A mechanistic study of the proapoptotic effect of tolfenamic acid: involvement of NF-κB activation. Carcinogenesis 34:2350-2360.
DOI
|
15 |
Holland, T.A., J. Elder, J.M. McCloud, C. Hall, M. Deakin, A.A. Fryer, J.B. Elder and P.R. Hoban. Subcellular localisation of cyclin D1 protein in colorectal tumours is associated with p21 (WAF1/CIP1) expression and correlates with patient survival. Int. J. Cancer 95:302-306.
DOI
|
16 |
Thoms, H.C., M.G. Dunlop and L.A. Stark. 2007. p38-mediated inactivation of cyclin D1/cyclin-dependent kinase 4 stimulates nucleolar translocation of RelA and apoptosis in colorectal cancer cells. Cancer Res. 67:1660-1669.
DOI
|
17 |
Stark, L.A., F.V. Din, R.M. Zwacka and M.G. Dunlop. 2001. Aspirin-induced activation of the NF-kappaB signaling pathway: a novel mechanism for aspirin-mediated apoptosis in colon cancer cells. FASEB J. 15:1273-1275.
DOI
|
18 |
Spinella, M.J., S.J. Freemantle, D. Sekula, J.H. Chang, A.J. Christie and E. Dmitrovsky. 1999. Retinoic acid promotes ubiquitination and proteolysis of cyclin D1 during induced tumor cell differentiation. J. Biol. Chem. 274:22013-22018.
DOI
|
19 |
Shao, H.J., Z. Lou, J.B. Jeong, K.J. Kim, J. Lee and S.H. Lee. 2015. Tolfenamic acid suppresses inflammatory-mediated activation of NF-κB signaling. Biomol. Ther. 23:39-44.
DOI
|
20 |
Park, G.H., J.H. Park, H.J. Eo, H.M. Song, M.H. Lee, J.R. Lee and J.B. Jeong. 2014b. Anti-inflammatory effect of the extracts from Abeliophyllum distichum Nakai in LPSstimulated RAW264.7 cells. Korean J. Plant Res. 27:209-214.
DOI
|
21 |
Park, G.H., J.H. Park, H.J. Eo, H.M. Song, S.H. Woo, M.K. Kim, J.W. Lee, M.H. Lee, J.R. Lee, J.S. Koo and J.B. Jeong. 2014a. The induction of activating transcription factor 3 (ATF3) contributes to anti-cancer activity of Abeliophyllum distichum Nakai in human colorectal cancer cells. BMC Complementary Alt. Med. 14:487.
DOI
|
22 |
Okabe, H., S.H. Lee, J. Phuchareon, D.G. Albertson, F. McCormick and O. Tetsu. 2006 A critical role for FBXW8 and MAPK in cyclin D1 degradation and cancer cell proliferation. PloS One 1:e128.
DOI
|
23 |
Oh, H., D.G. Kang, T.O. Kwon, K.K. Jang, K.Y. Chai, Y.G. Yun, H.T. Chung and H.S. Lee. 2003. Four glycosides from the leaves of Abeliophyllum distichum with inhibitory effects on angiotensin converting enzyme. Phytother. Res. 17:811-819.
DOI
|
24 |
Weinberg, R.A. 1995. The retinoblastoma protein and cell cycle control. Cell 81:323-330.
DOI
|
25 |
Verma, I.M. 2004. Nuclear factor (NF)-kappaB proteins: therapeutic targets. Ann. Rheum. Dis. 63:57-61.
|